| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.062 | 0.7 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.043 | 0.7 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |